Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
MGMT Promoter Methylation Testing to Predict Overall Survival in People With Glioblastoma Treated With Temozolomide: A Comprehensive Meta-Analysis Based on a Cochrane Systematic ReviewNeuro-oncology 2021 Sep 01;23(9)1457-1469, S Brandner, A McAleenan, C Kelly, F Spiga, HY Cheng, S Dawson, L Schmidt, CL Faulkner, C Wragg, S Jefferies, JPT Higgins, KM Kurian
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.